Powered by
LAKELAND–Abionyx Pharma reported that the pilot Phase 2a clinical trial evaluating its drug candidate CER-001, the only natural recombinant apoA-I, as a treatment for septic patients at high risk of …
ANN ARBOR–CareEvolution has announced a membership with the Decentralized Trials & Research Alliance (DTRA) to collaborate in the efforts to improve global adoption and education surrounding decentralized research, participant-centric trial …
CANTON TWP.—Officials at MMS Holdings Inc., a contract research organization for the pharmaceutical industry, announced a pro-bono support program to advance research for ultra-rare diseases. Within this program, MMS will …
CANTON TWP.—Officials at MMS Holdings, the Canton Township-based contract pharmaceutical research firm, announced that the company’s MMS Academy has launched new courses in inspection readiness and clinical programming for clinical …
GRAND RAPIDS—Officials at Tetra Therapeutics, a pharma startup developing drugs to treat brain disorders associated with cognitive and memory deficits, announced that CEO Mark Gurney had retired effective June 30. …
PRINCETON, N.J.—Certara (Nasdaq: CERT), the New Jersey-based biosimulation company, has licensed the Anonymize software to anonymize clinical data from Canton Township-based TrialAssure. TrialAssure’s Anonymize allows clinical trial sponsors to anonymize …
CANTON TWP.–MMS Holdings, a contract research organization for the pharmaceutical industry, has joined the Decentralized Trials and Research Alliance, an organization launched in December to unite healthcare companies, regulators, patient …
DETROIT—Officials at the Karmanos Cancer Institute in Detroit have announced the launch of a new clinical trials study information portal (SIP) at www.karmanos.org/opentrials. The SIP website, which is integrated with …
ANN ARBOR—HistoSonics Inc. announced that it had received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its new technology, …
CANTON TWP.—MMS Holdings Inc. said that its collaboration with Shanghai-based Green Valley Pharmaceutical Co. resulted in gaining U.S. Food & Drug Administration approval of an Investigational New Drug application for …